Bridgebio Oncology Therapeutics, Inc. · NASDAQ:BBOT
Adage Capital Management, L.P.'s stake in Bridgebio Oncology Therapeutics, Inc. fell to 1.88% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 13, 2025
Adage Capital Management, L.P.'s stake in Bridgebio Oncology Therapeutics, Inc. fell to 1.88%, 1,487,621 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G/A).
- Stake
- 1.88%
- Shares
- 1,487,621
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 1.88% | 1,487,621 |
| Robert Atchinson | 1.88% | 1,487,621 |
| Phillip Gross | 1.88% | 1,487,621 |